Whitestown radiopharmaceutical manufacturing facility
RayzeBio (Bristol Myers Squibb), Whitestown, Boone County, Indiana
Whitestown radiopharmaceutical manufacturing facility in Whitestown, Indiana is RayzeBio (Bristol Myers Squibb)’s plant for actinium-based radiopharmaceutical cancer therapies. Status: announced as of August 27, 2026. RayzeBio (Bristol Myers Squibb) announced $173 million and 100 jobs. Primary source: events.in.gov, checked November 12, 2026.
- Status
- Announced
- Announced investment
- $173 million
- Announced jobs
- 100
- Industry
- Pharmaceuticals
- Sheet
- IN-25
- Revised
- November 12, 2026
Status timeline
- Announcedevents.in.gov
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | RayzeBio (Bristol Myers Squibb) |
|---|---|
| Plant | Whitestown radiopharmaceutical manufacturing facility |
| Location | Whitestown, Boone County, Indiana |
| Industry | Pharmaceuticals |
| Product | Actinium-based radiopharmaceutical cancer therapies |
| Announced investment | $173 millionMore than $173M across new Whitestown facility and existing Indianapolis site. |
| Announced jobs | 100 |
| Last checked | November 12, 2026 |
Sources
- State of Indiana: $173 million RayzeBio investment, 100 new jobs (state release, events.in.gov, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.